Arcus Biosciences, Inc. (RCUS:NYSE) soared at $29.5, representing a gain of 89.3%. The stock appeared on our News Catalysts scanner on Thu 16 Apr 20 at 04:58 PM in the 'BIOTECH' category. From Wed 01 Apr 20, the stock recorded 66.67% Up Days and 60.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Arcus Biosciences, Inc. (RCUS:NYSE)
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company which focuses on developing and commercializing cancer immunotherapies.
Top 10 Gainers:
- Taronis Technologies, Inc. (TRNX:NASDAQ), 109.09%
- Arcus Biosciences, Inc. (RCUS:NYSE), 89.35%
- MoSys, Inc. (MOSY:NASDAQ), 87.5%
- Yunhong CTI Ltd. (CTIB:NASDAQ), 61.04%
- Edison Nation, Inc. (EDNT:NASDAQ), 53.89%
- Consumer Portfolio Services, Inc. (CPSS:NASDAQ), 51.92%
- ThermoGenesis Holdings, Inc. (THMO:NASDAQ), 43.79%
- Co-Diagnostics, Inc. (CODX:NASDAQ), 43.68%
- SPI Energy Co., Ltd. (SPI:NASDAQ), 38.71%
- Atossa Therapeutics, Inc. (ATOS:NASDAQ), 37.91%